Eli Lilly and Co (LLY) - Financial and Strategic SWOT Analysis Review
Eli Lilly and Co (LLY) Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Eli Lilly and Co (Lilly) is a healthcare company that discovers, develops and markets human healthcare products. The company offers medicines for cardiovascular conditions, diabetes, endocrinology, cancer, neurological problems, immune disorders, men's health and musculoskeletal problems. The company distributes its pharmaceutical health products through independent wholesale distributors. It also promotes products through sales representatives and marketing agreements with other pharmaceutical companies. The company also offers its products in North America, South America, Europe, South Asia, the Middle East, Africa and North Asia-Pacific. Lilly is headquartered in Indianapolis, Indiana, the US.
Eli Lilly and Co Key Recent Developments
Jul 26,2021: Taoiseach opens Ireland’s largest solar farm and expansion to biotech facility
Jul 22,2021: Menarini Asia-Pacific strengthens Men’s Health portfolio in China with acquisition of Cialis (Tadalafil) from Lilly
Jul 16,2021: Lilly partners with Banner Alzheimer's for donanemab’s Phase III trial
Jul 14,2021: Lilly acquires biotech firm Protomer for $1bn
Jul 09,2021: Lilly and Verge Genomics partner to use AI for drug development
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Eli Lilly and Co (Lilly) is a healthcare company that discovers, develops and markets human healthcare products. The company offers medicines for cardiovascular conditions, diabetes, endocrinology, cancer, neurological problems, immune disorders, men's health and musculoskeletal problems. The company distributes its pharmaceutical health products through independent wholesale distributors. It also promotes products through sales representatives and marketing agreements with other pharmaceutical companies. The company also offers its products in North America, South America, Europe, South Asia, the Middle East, Africa and North Asia-Pacific. Lilly is headquartered in Indianapolis, Indiana, the US.
Eli Lilly and Co Key Recent Developments
Jul 26,2021: Taoiseach opens Ireland’s largest solar farm and expansion to biotech facility
Jul 22,2021: Menarini Asia-Pacific strengthens Men’s Health portfolio in China with acquisition of Cialis (Tadalafil) from Lilly
Jul 16,2021: Lilly partners with Banner Alzheimer's for donanemab’s Phase III trial
Jul 14,2021: Lilly acquires biotech firm Protomer for $1bn
Jul 09,2021: Lilly and Verge Genomics partner to use AI for drug development
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
SECTION 1 - ABOUT THE COMPANY
Eli Lilly and Co - Key Facts
Eli Lilly and Co - Key Employees
Eli Lilly and Co - Key Employee Biographies
Eli Lilly and Co - Major Products and Services
Eli Lilly and Co - History
Eli Lilly and Co - Company Statement
Eli Lilly and Co - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
SECTION 2 – COMPANY ANALYSIS
Company Overview
Eli Lilly and Co - Business Description
Product Category: Diabetes
Performance
Product Category: Immunology
Performance
Product Category: Neuroscience
Performance
Product Category: Oncology
Performance
Product Category: Other
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Japan
Performance
Geographical Segment: Other Foreign Countries
Performance
Geographical Segment: United States
Performance
R&D Overview
Eli Lilly and Co - Corporate Strategy
Eli Lilly and Co - SWOT Analysis
SWOT Analysis - Overview
Eli Lilly and Co - Strengths
Eli Lilly and Co - Weaknesses
Eli Lilly and Co - Opportunities
Eli Lilly and Co - Threats
Eli Lilly and Co - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Eli Lilly and Co, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Eli Lilly and Co, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Eli Lilly and Co, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Jul 26, 2021: Taoiseach opens Ireland’s largest solar farm and expansion to biotech facility
Jul 16, 2021: Lilly partners with Banner Alzheimer's for donanemab’s Phase III trial
Jul 09, 2021: Lilly and Verge Genomics partner to use AI for drug development
Jun 24, 2021: Lilly announces call for Leonard Award nominations as part of global initiative celebrating 100 years of insulin
Jun 17, 2021: Lilly launches Think Talk Treat Migraine to help improve diagnosis and treatment of migraine
May 28, 2021: US DOJ probes Eli Lilly’s Branchburg manufacturing site
May 27, 2021: Eli Lilly and Co: Received a subpoena from the U.S. Department of Justice
May 19, 2021: Lilly announces details of presentations at 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
May 17, 2021: Natco Pharma and Lilly sign licencing deal for baricitinib use in India
May 05, 2021: Lilly to Participate in Bank of America Securities 2021 Health Care Conference
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
Eli Lilly and Co - Key Facts
Eli Lilly and Co - Key Employees
Eli Lilly and Co - Key Employee Biographies
Eli Lilly and Co - Major Products and Services
Eli Lilly and Co - History
Eli Lilly and Co - Company Statement
Eli Lilly and Co - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
SECTION 2 – COMPANY ANALYSIS
Company Overview
Eli Lilly and Co - Business Description
Product Category: Diabetes
Performance
Product Category: Immunology
Performance
Product Category: Neuroscience
Performance
Product Category: Oncology
Performance
Product Category: Other
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Japan
Performance
Geographical Segment: Other Foreign Countries
Performance
Geographical Segment: United States
Performance
R&D Overview
Eli Lilly and Co - Corporate Strategy
Eli Lilly and Co - SWOT Analysis
SWOT Analysis - Overview
Eli Lilly and Co - Strengths
Eli Lilly and Co - Weaknesses
Eli Lilly and Co - Opportunities
Eli Lilly and Co - Threats
Eli Lilly and Co - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Eli Lilly and Co, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Eli Lilly and Co, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Eli Lilly and Co, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Jul 26, 2021: Taoiseach opens Ireland’s largest solar farm and expansion to biotech facility
Jul 16, 2021: Lilly partners with Banner Alzheimer's for donanemab’s Phase III trial
Jul 09, 2021: Lilly and Verge Genomics partner to use AI for drug development
Jun 24, 2021: Lilly announces call for Leonard Award nominations as part of global initiative celebrating 100 years of insulin
Jun 17, 2021: Lilly launches Think Talk Treat Migraine to help improve diagnosis and treatment of migraine
May 28, 2021: US DOJ probes Eli Lilly’s Branchburg manufacturing site
May 27, 2021: Eli Lilly and Co: Received a subpoena from the U.S. Department of Justice
May 19, 2021: Lilly announces details of presentations at 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
May 17, 2021: Natco Pharma and Lilly sign licencing deal for baricitinib use in India
May 05, 2021: Lilly to Participate in Bank of America Securities 2021 Health Care Conference
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
Eli Lilly and Co, Key Facts
Eli Lilly and Co, Key Employees
Eli Lilly and Co, Key Employee Biographies
Eli Lilly and Co, Major Products and Services
Eli Lilly and Co, History
Eli Lilly and Co, Subsidiaries
Eli Lilly and Co, Joint Venture
Eli Lilly and Co, Key Competitors
Eli Lilly and Co, Ratios based on current share price
Eli Lilly and Co, Annual Ratios
Eli Lilly and Co, Annual Ratios (Cont...1)
Eli Lilly and Co, Annual Ratios (Cont...2)
Eli Lilly and Co, Interim Ratios
Eli Lilly and Co, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Eli Lilly and Co, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Eli Lilly and Co, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
Eli Lilly and Co, Key Facts
Eli Lilly and Co, Key Employees
Eli Lilly and Co, Key Employee Biographies
Eli Lilly and Co, Major Products and Services
Eli Lilly and Co, History
Eli Lilly and Co, Subsidiaries
Eli Lilly and Co, Joint Venture
Eli Lilly and Co, Key Competitors
Eli Lilly and Co, Ratios based on current share price
Eli Lilly and Co, Annual Ratios
Eli Lilly and Co, Annual Ratios (Cont...1)
Eli Lilly and Co, Annual Ratios (Cont...2)
Eli Lilly and Co, Interim Ratios
Eli Lilly and Co, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Eli Lilly and Co, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Eli Lilly and Co, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
LIST OF FIGURES
Eli Lilly and Co, Performance Chart (2016 - 2020)
Eli Lilly and Co, Ratio Charts
Eli Lilly and Co, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Eli Lilly and Co, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021
Eli Lilly and Co, Performance Chart (2016 - 2020)
Eli Lilly and Co, Ratio Charts
Eli Lilly and Co, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Eli Lilly and Co, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021